
معرفی
Dr. Benayahu Elbaz-eilon serves as an Assistant Professor in the Department of Neurology at Northwestern University's Feinberg School of Medicine, specializing in the MS/Neuroimmunology division. His research program focuses on the molecular mechanisms regulating myelin-forming cells in both central and peripheral nervous systems.
- BS: Bar-Ilan University (2002)
- MS: Bar-Ilan University (2004)
- PhD: The Hebrew University of Jerusalem (2010)
- Postdoctoral Training: University of Chicago, Neuroscience (2016)
Dr. Elbaz-eilon's research centers on transcriptional control of oligodendrocyte differentiation and CNS myelination, with particular emphasis on the ZFP24 transcription factor. His laboratory investigates how oligodendrocyte lineage cells shape the brain's extracellular matrix and explores metabolic pathways protecting against lipid peroxidation. In the peripheral nervous system, his team studies injury mechanisms, recovery processes, and remyelination following damage to Schwann cells. His work bridges fundamental developmental neurobiology with translational applications for demyelinating disorders like multiple sclerosis.
Analysis of Dr. Elbaz-eilon's publication record reveals a consistent research trajectory focused on myelin biology, with recent work (2020-2024) increasingly emphasizing transcriptional regulation in oligodendrocytes, neuron-glia interactions, and the molecular basis of demyelinating diseases. His publications span high-impact journals including Neuron, Cell Reports, and Nature Nanotechnology, demonstrating interdisciplinary approaches combining molecular neuroscience with advanced bioengineering techniques.
Dr. Elbaz-eilon leads an active research laboratory with current staff including Research Technologists Haley Tokars and Tanya Klein. His laboratory is part of Northwestern's Neuroimmunology Research program, collaborating with the Popko Lab and other neuroscience research groups within the Feinberg School of Medicine. He serves on the Editorial Board of Frontiers in Cellular Neuroscience (2023-present) and is a member of the American Society for Neurochemistry (2022-present).




.jpg?sfvrsn=292162bb_2)
